Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Jugoh Itoh"'
Autor:
Yuichi Kato, Jugoh Itoh, Masaharu Wano, Naoto Takahashi, Kazunori Murai, Kenichi Ishizawa, Yoji Ishida, Tomoaki Akagi, Hideyoshi Noji, Katsushi Tajima, Hideo Harigae, Osamu Sasaki, Tsutomu Scichishima, Kenichi Sawada
Publikováno v:
Journal of Medical Virology. 88:2206-2210
Occult hepatitis B virus (HBV) infection is a clinical challenge, but its relationship to clinicopathologic features and the risk of progression to malignant lymphoma (ML) are poorly defined. We estimated the prevalence of HBV infection of 1,358 pati
Autor:
Katsushi Tajima, Kenichi Ishizawa, Tsutomu Shichishima, Osamu Sasaki, Jugoh Itoh, Hideyoshi Noji, Naoto Takahashi, Tomoaki Akagi, Yuichi Kato, Masaharu Wano, Kazunori Murai, Yoji Ishida, Hideo Harigae
Publikováno v:
Leukemia & Lymphoma. 58:1509-1511
Chronic hepatitis C virus (HCV) infection conditions are proposed to be an HCV syndrome of hepatic, extrahepatic or systemic disorders with malignancies such as a malignant lymphoma (ML).[1] HCV is...
Autor:
Katsushi, Tajima, Naoto, Takahashi, Kenichi, Ishizawa, Kazunori, Murai, Tomoaki, Akagi, Hideyoshi, Noji, Osamu, Sasaki, Masaharu, Wano, Jugoh, Itoh, Yuichi, Kato, Tsutomu, Scichishima, Yoji, Ishida, Hideo, Harigae, Kenichi, Sawada
Publikováno v:
Journal of medical virology. 88(12)
Occult hepatitis B virus (HBV) infection is a clinical challenge, but its relationship to clinicopathologic features and the risk of progression to malignant lymphoma (ML) are poorly defined. We estimated the prevalence of HBV infection of 1,358 pati
Autor:
Jugoh Itoh, Hiroyuki Mizuguchi, Takenori Takahata, Hong Xin, Yasuo Saijo, Masahiko Kanehira, Ruowen Sun
Publikováno v:
Molecular Medicine. 15:321-327
The lung is one of the organs to which cancers from solid tumors frequently metastasize. Multiple tumors in the lung are usually treated by systemic chemotherapy because of the lack of efficient methods of targeting antitumor agents to the lung. Alth
Publikováno v:
Neuroscience Letters. 432:217-221
Inflammatory bowel disease (IBD) consists of Crohn's disease (CD) and ulcerative colitis (UC). The etiology has not been clarified yet, but immune disorder is thought to be involved in the pathogenic physiology. Recently, general consensus has been r
Publikováno v:
Chinese Journal of Digestive Diseases. 4:9-12
OBJECTIVE: To investigate the in vitro effect of Tripterygium glycosides (TG) on cytokine production by splenocytes in oxazolone (OXZ)-induced colitis in mice. METHODS: Oxazolone (6 mg in 50% ethanol) was administered to male SJL/J mice intrarectally
Autor:
Atsushi, Ishiguro, Takenori, Takahata, Yoshifumi, Matsumoto, Satoshi, Tanaka, Jugoh, Itoh, Hitoshi, Kawasaki, Yasuyuki, Kudoh, Hiroshi, Kijima, Sen, Shimaya, Yasuo, Saijo
Publikováno v:
Gan to kagaku ryoho. Cancerchemotherapy. 39(3)
The standard regimen of S-1 and cisplatin is not adaptable for patients with gastric cancer with an ingestion inability. A 74- year-old man was revealed to have unresectable gastric cancer with severe pyloric stenosis(cT4, cN3, cH1, cP0, cStage IV).
Autor:
Takenori Takahata, Qiliang Zhou, Ruowen Sun, Jugoh Itoh, Atsushi Ishiguro, Shinsaku Fukuda, Hiroshi Kijima, Xulu Ye, Naoyuki Hanada, Ken Itoh, Junsei Mimura, Yasuo Saijo
Publikováno v:
BMC Cancer, Vol 12, Iss 1, p 66 (2012)
BMC Cancer
BMC Cancer
Background The Keap1-Nrf2 pathway has been reported to be impaired in several cancers. However, the status of Keap1-Nrf2 system in human colorectal cancer (CRC) has not been elucidated. Methods We used colorectal cancer (CRC) cell lines and surgical
Autor:
Shinsaku Fukuda, Taroh Satoh, Takenori Takahata, Soh Saitoh, Yasuo Saijo, Yoshifumi Matsumoto, Jugoh Itoh, Satoshi Tanaka, Yuh Sakata, Atsushi Ishiguro, Hiroshi Tohno
Irinotecan hydrochloride (CPT-11) is reported to be involved in the downregulation of thymidylate synthase (TS), a target molecule of 5-fluorouracil (5-FU) and oral fluoropyrimidine S-1. Therefore, we hypothesized that a preceding administration of C
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::203948dc01a79a86c2e1cda22b7682fc
https://europepmc.org/articles/PMC3362594/
https://europepmc.org/articles/PMC3362594/
Autor:
Junnichi Kameoka, Tsutomu Shichishima, Shigeki Ito, Kazuhiko Ikeda, Yoji Ishida, Naoto Takahashi, Kouhei Yamaguchi, Hideo Harigae, Jugoh Itoh, Kenichi Ishizawa, Kazunori Murai, Yoshihiro Kameoka, Yuichi Kato, Ryo Ichinohasama, Katsushi Tajima, Hideyoshi Noji, Kenichi Sawada, Tomoaki Akagi
Publikováno v:
Journal of clinical and experimental hematopathology : JCEH. 51(1)
To clarify the clinical outcome of peripheral T-cell lymphomas (PTCLs), we conducted a retrospective review comparing the outcomes of patients with PTCL (nodal peripheral T-cell lymphoma, unspecified, n=34 ; angioimmunoblastic T-cell lymphoma, n=12)